AstraZeneca becomes latest drugmaker to strike deal with Trump. Its stock is climbing after hours.

AstraZeneca announced a deal with U.S. President Donald Trump that’s focused on lowering drug prices, in a move that would see the British drugmaker follow in the footsteps of Pfizer.

Previous Article

Crypto bulls were amped for potential solana ETF approvals this week. But the government shutdown threw it into limbo.

Next Article

Portland Leftists Plan 'Laser Tag' Attacks On Federal Aircraft Saturday Night

Write a Comment

Leave a Comment

Your email address will not be published. Required fields are marked *

Subscribe to our Newsletter

Subscribe to our email newsletter to get the latest posts delivered right to your email.
Pure inspiration, zero spam ✨